SEC Form 4 · accession 0001053369-18-000002
ELITE PHARMACEUTICALS INC /NV/ · ELTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barry H Dash
Director
Period of report
Feb 26, 2018
Accepted (ET)
Feb 27, 2018 · 4:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053369
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 26, 2018 | A | 161,374 | $0.1239 | A | 1,415,831 | D |
Table II — derivative securities
No Table II lines on this filing.